
Liom is developing the ultimate wearable device that offers non-invasive glucose monitoring seamlessly integrated with other health metrics. Their technology provides precision glucose measurements without piercing the skin, a claimed world first. The company focuses on several key health areas including metabolic health, fitness, cardiovascular health, sleep, and mental well-being, all informed by real-time physiological data. Liom aims to empower individuals with awareness for disease prevention by tracking subtle irregularities in glucose metabolism. The company has achieved ISO 13485:2016 certification for the design and development of non-invasive medical devices.

Liom is developing the ultimate wearable device that offers non-invasive glucose monitoring seamlessly integrated with other health metrics. Their technology provides precision glucose measurements without piercing the skin, a claimed world first. The company focuses on several key health areas including metabolic health, fitness, cardiovascular health, sleep, and mental well-being, all informed by real-time physiological data. Liom aims to empower individuals with awareness for disease prevention by tracking subtle irregularities in glucose metabolism. The company has achieved ISO 13485:2016 certification for the design and development of non-invasive medical devices.
Headquarters: Pfäffikon / Freienbach, Zurich region, Switzerland
Core product: Wearable, non-invasive continuous blood biomarker monitoring (initially glucose) using light + AI
Founder / CEO: Leo Grünstein
Employee count: 72
Regulatory/certification: ISO 13485:2016 for design and development of non-invasive medical devices
Non-invasive continuous biomarker monitoring for metabolic and overall health insights.
2017
Health technology / Wearables / Medical devices
Seed round listed on business databases with multiple investors
25000000.00
Series A reported in databases (amount reported by some databases)
“Edward Ludwig and b2venture listed among investors; databases report eight investors in total”